Ember LifeSciences Raises $16.5M in Series A Funding led by Sea Court Capital to advance its cold chain technology pipeline, including the Ember Cube 2.
Amount Raised
$16.5 Million
Round Type
Series A
Investors
Description
Ember LifeSciences, a Los Angeles-based provider of cold chain technology, has raised $16.5M in Series A funding. The round was led by Sea Court Capital, with participation from Cardinal Health and Carrier Ventures. The funds will be used to launch the Ember Cube 2 and enhance their temperature control technology. The company aims to transform global medicine distribution.
Quick answer
Ember LifeSciences raised $16.5 Million in a Series A round, dated December 16, 2025. Investors: Cardinal Health, Carrier Ventures, Mike Pompeo and Sea Court Capital. Ember LifeSciences is based in Westlake Village, California, United States.
- How much did Ember LifeSciences raise?
- Ember LifeSciences raised $16.5 Million in a Series A round on December 16, 2025.
- Who invested in Ember LifeSciences?
- Cardinal Health, Carrier Ventures, Mike Pompeo and Sea Court Capital are named as investors in this round.
- What does Ember LifeSciences do?
- Ember LifeSciences is redefining global medicine distribution through leveraging Ember’s proprietary temperature control technology to improve the way we transport life-saving medicines and vaccines around the world.
- Where is Ember LifeSciences based and how big is it?
- Ember LifeSciences is based in Westlake Village, California, United States. Fundz records about 24 employees.
- Who are the decision-makers at Ember LifeSciences?
- Fundz holds 3 contacts at Ember LifeSciences, including the General Manager. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Ember LifeSciences that raised within 45 days of this round, from Fundz verified event records.
- ORamaVR raised $4.5M (Seed) on January 30, 2026.
- CytoDyn raised $19M on January 30, 2026.
- Richtech Robotics raised $39M (Post-IPO Equity) on January 29, 2026.
- Biopeak raised $2.7M (Seed) on January 29, 2026.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
- PranaX raised $17M (Series A) on January 29, 2026.
Who to call at Ember LifeSciences, and when
A new round usually means Ember LifeSciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ember LifeSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ember LifeSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ember LifeSciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ember LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEmber LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.